Skip to Main Content

Author Details

Emilie Battivelli
A Division of Janssen Pharmaceutica NV
2010
16
11
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37874295A truncated HIV Tat demonstrates potent and specific latency reversal activity.Antimicrob Agents Chemother2023
34531866The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency.Front Immunol2021
33504604CAGE-seq reveals that HIV-1 latent infection does not trigger unique cellular responses in a Jurkat T cell model.J Virol2021
32541947FOXO1 promotes HIV latency by suppressing ER stress in T cells.Nat Microbiol2020
32755584Sialyl-Lewis[X] Glycoantigen Is Enriched on Cells with Persistent HIV Transcription during Therapy.Cell Rep2020
29714165Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4<sup>+</sup> T cells.Elife2018
33644255HIV<sub>GKO</sub>: A Tool to Assess HIV-1 Latency Reversal Agents in Human Primary CD4<sup>+</sup> T Cells.Bio Protoc2018
29802019Anti-apoptotic Protein BIRC5 Maintains Survival of HIV-1-Infected CD4<sup>+</sup> T Cells.Immunity2018
27428435LEDGIN-mediated Inhibition of Integrase-LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV.EBioMedicine2016
27978436The mTOR Complex Controls HIV Latency.Cell Host Microbe2016
25587657Understanding HIV latency: the road to an HIV cure.Annu Rev Med2015
23320071Delaying reverse transcription does not increase sensitivity of HIV-1 to human TRIM5α.PLoS One2013
23864638Pressure from TRIM5α contributes to control of HIV-1 replication by individuals expressing protective HLA-B alleles.J Virol2013
21632761Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoforms.J Virol2011
21917976Gag cytotoxic T lymphocyte escape mutations can increase sensitivity of HIV-1 to human TRIM5alpha, linking intrinsic and acquired immunity.J Virol2011
20702630Strain-specific differences in the impact of human TRIM5alpha, different TRIM5alpha alleles, and the inhibition of capsid-cyclophilin A interactions on the infectivity of HIV-1.J Virol2010
  • 1 - 16 of 16

Recommended Authors

Peter W Ramirez
California State University Long Beach
Career Start Year 2014
Number of shared co-authors 1
Daniele C Cary
University of California san francisco
Career Start Year 2011
Number of shared co-authors 0
Chi N Chan
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 1
Suzannah J Rihn
MRC-University of Glasgow Centre for Virus Research, University of Glasgow
Career Start Year 2008
Number of shared co-authors 3
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Career Start Year 2008
Number of shared co-authors 4
Anastasia Selyutina
Albert Einstein College of Medicine
Career Start Year 2005
Number of shared co-authors 1
Mary K Lewinski
University of California
Career Start Year 2005
Number of shared co-authors 4
Lara Manganaro
National Institute of Molecular Genetics, "Fondazione Romeo ed Enrica Invernizzi"
Career Start Year 2005
Number of shared co-authors 1
Felipe Diaz-Griffero
Albert Einstein College of Medicine
Career Start Year 2002
Number of shared co-authors 1
Timothy J Henrich
University of California san francisco
Career Start Year 2002
Number of shared co-authors 11
Edward P Browne
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 0
Alberto Bosque
George Washington University
Career Start Year 2000
Number of shared co-authors 6
Maudi Killian
University of California San Francisco
Career Start Year 1999
Number of shared co-authors 1
Renate K??nig
Paul-Ehrlich-Institut
Career Start Year 1998
Number of shared co-authors 3
Viviana Simon
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 1
Greg J Towers
University College London
Career Start Year 1995
Number of shared co-authors 1
Theodora Hatziioannou
The Rockefeller University
Career Start Year 1995
Number of shared co-authors 0
Wei Shao
Inc., Frederick National Laboratory for Cancer Research
Career Start Year 1993
Number of shared co-authors 2
Sharon R Lewin
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 7
Paul D Bieniasz
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 0
Vicente Planelles
University of Utah
Career Start Year 1991
Number of shared co-authors 8
Olivier Schwartz
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 4
Bruce D Walker
Ragon Institute of Mass General
Career Start Year 1987
Number of shared co-authors 3
Mohan Somasundaran
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 1
Michael Emerman
Fred Hutchinson Cancer Center
Career Start Year 1982
Number of shared co-authors 5
Steven M Wolinsky
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 7
John Guatelli
University of California San Diego, USA VA San Diego Healthcare System
Career Start Year 1978
Number of shared co-authors 6
Jeffrey D Lifson
Frederick National Laboratory
Career Start Year 1977
Number of shared co-authors 11
Ronald Swanstrom
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 1972
Number of shared co-authors 4
Douglas D Richman
Center for AIDS Research, University of California San Diego
Career Start Year 1970
Number of shared co-authors 5

Collaborators

Eric Verdin
Buck Institute for Research on Aging
Co-authored papers 10
Françoise Clavel-Chapelon
Co-authored papers 5
Andrea Gramatica
Gladstone Institute of Virology, Gladstone Institutes
Co-authored papers 2
Melanie Ott
Gladstone Institute of Virology
Co-authored papers 2
Steven G Deeks
University of California san francisco
Co-authored papers 2
Warner C Greene
Gladstone Institute of Virology, USA University of California san francisco
Co-authored papers 2
Emilie Besnard
Gladstone Institute of Virology, Gladstone Institutes
Co-authored papers 2
J Peter Svensson
Karolinska Institutet
Co-authored papers 2
Satish K Pillai
Vitalant Research Institute, USA University of California san francisco
Co-authored papers 2
Hyung W Lim
Gladstone Institute of Virology and Immunology
Co-authored papers 1
Andrew E Rosenberg
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Kotaro Shirakawa
Graduate School of Medicine, Kyoto University
Co-authored papers 1
Marius Walter
Buck Institute for Research on Aging
Co-authored papers 1
Nadia R Roan
University of California, USA Gladstone Institutes san francisco
Co-authored papers 1
Steven A Carr
Broad Institute of MIT and Harvard
Co-authored papers 1
Jonas Demeulemeester
VIB-KU Leuven Center for Cancer Biology
Co-authored papers 1
Andrew V Kossenkov
The Wistar Institute
Co-authored papers 1
Jonathan Chan
From the Gladstone Institute of Virology and Immunology
Co-authored papers 1
Erik Verschueren
University of California San Francisco
Co-authored papers 1
Albert Vallejo-Gracia
Gladstone Institute of Virology, Gladstone Institutes
Co-authored papers 1
Daniela Boehm
University College Dublin
Co-authored papers 1
Michael C Bassik
Stanford University Medical Center
Co-authored papers 1
Opeyemi S Adeniji
The Wistar Institute
Co-authored papers 1
Nina N Hosmane
Johns Hopkins University School of Medicine
Co-authored papers 1
Shweta Hakre
AstraZeneca Pharmaceuticals
Co-authored papers 1
Robert F Siliciano
Johns Hopkins University School of Medicine
Co-authored papers 1
Alyssa R Martin
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
Martin Kampmann
Institute for Neurodegenerative Diseases, University of California san francisco
Co-authored papers 1
Ryan J Conrad
Genentech Inc.
Co-authored papers 1
Release 1.2